drugset / Trial / NCT00030264

Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas

NCT00030264

Phase 2 Completed 23 enrolled Children's Hospital of Philadelphia
NaSingle-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining methotrexate with vinblastine may be effective treatment for neurofibromatosis type 1 associated with progressive plexiform neurofibromas. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients who have neurofibromatosis type 1 associated with progressive plexiform neurofibromas.

Timeline

Start
2001-02
Primary completion
2013-12
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Methotrexate Small molecule 30 mg/m2 Intramuscular
Subject Vinblastine Small molecule 6 mg/m2 Intravenous